Trials / Completed
CompletedNCT04503863
An Additional Study of NPC-22 in Healthy Adult Males
Additional Phase 1 Study of NPC-22 for High Dosage in Healthy Adult Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the safety and pharmacokinetics of high dose NPC-22 administration in healthy adult males. The effect of administration routes for pharmacokinetics will be examined in advance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-22 | Single administration of middle dose NPC-22 |
| DRUG | NPC-22 | Single administration of high dose NPC-22 |
| DRUG | NPC-22 Placebo | Single administration of NPC-22 Placebo |
Timeline
- Start date
- 2020-07-20
- Primary completion
- 2020-11-06
- Completion
- 2021-12-28
- First posted
- 2020-08-07
- Last updated
- 2022-02-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04503863. Inclusion in this directory is not an endorsement.